TERI RUTHERFORD: Open Payments
NPI 1063885085 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 35 payments from 19 companies in 2025. Trend: 2023 $821 · 2024 $1,133 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $179 |
| Astellas Pharma US Inc | 4 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $112 |
| Novo Nordisk Inc | 5 | $111 |
| GlaxoSmithKline, LLC. | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| SI-BONE, INC. | 1 | $26 |
| Globus Medical, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: Dexcom G6 Transmitter, Veozah, Kerendia, TRELEGY ELLIPTA, Wegovy, OFEV, Senza, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
